Antibodies market growth potential in North America is anticipated to be driven by substantial spending in healthcare research and development. By the end of 2033, this regional market is anticipated to hold close to 49% of the global antibodies market share.

The Antibodies Market is projected to reach US$ 236.9 billion in 2023 and is expected to grow at a CAGR of 13.4% from 2023 to 2033. The market for antibodies is predicted to reach US$ 834.2 Bn by 2033. The global market’s absolute dollar increase represents the entire market value of the antibodies industry at US$ 597.3 Bn.

According to Future Market Insights, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in upcoming decades, surpassing US$ 601.614 Billion by the end of 2031.

As per FMI studies, the leading players in the antibodies market include F. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services, Inc., Amgen Inc., and Bristol-Myers Squibb Company. These key players together account for 3 out of 4 sales of antibodies across the globe.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1330 

According to the reports of the National Stem Foundation (NSCF), about 4% of the global population is affected by some sort of autoimmune disease. The most common autoimmune diseases are diabetes, multiple sclerosis, Crohn’s disease, and rheumatoid arthritis. Due to these chronic diseases, the demand for antibodies market is estimated through the roof.

Key Insights

Antibodies are essential for treating medical conditions including autoimmune diseases, cancer, and several types of neurological diseases. Immunoglobulin (IG) is a type of antibody that is used for the prevention of lower respiratory tract infections and diseases caused by the vaccinia virus. Rising cases of viral infection will drive the demand for antibodies.

The prevalence of autoimmune diseases is on the rise, and they also have the potential to act as a host for multiple chronic ailments. Owing to these factors, the demand for antibodies is forecast to increase in upcoming years.

The COVID-19 pandemic boosted the demand for antibodies as patients suffering from COVID-19 were highly susceptible to contracting various other ailments and, in some cases, triggered autoimmune diseases in the patient.

Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1330 

A reasonable hike in research and development activities among healthcare and pharmaceutical market leaders are working towards developing effective and economical antibodies and biosimilar antibodies, propelling growth in the market.

Parkinson’s and Sclerosis diseases are on the rise among older people which is a key factor fueling the demand for antibodies. There is an urgency to develop cheap and personalized medicines, novel and effective treatments, and advanced therapeutics in middle-income countries which is expected to positively influence the sales of antibodies.

The widespread application of antibodies in chronic disease treatment is accelerating which is predicted to create scope for market expansion in the near future.

Competitive Landscape

Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, Eli Lilly, and Co. are some of the key companies profiled in the full version of the report.

Future Market Insights (FMI) has found that market players are working towards developing new antibodies to treat cancer and other diseases. They are also researching to create long-acting antibody drugs to reduce healthcare costs.

In order to gain a competitive edge in the antibodies market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1330 

More Insights into Antibodies Market

The United States is considered the dominant market in the North American region owing to modern healthcare infrastructural facilities and the presence of leading market players in the country. An increase in government funding and elevated purchasing power is expected to drive growth in the market.

The GCC countries led by Saudi Arabia are increasingly focusing on research and development on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. The contribution of antibodies is significant in this research. Hence, propelling growth in the market.

The development and production of antibodies are on a rise in China and are expected to surge significantly owing to increasing government investment in drugs and development coupled with growing awareness about various medical ailments like rheumatoid arthritis, cancer, and infections.

The Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with the development of the healthcare system in the country. According to the reports of the Global Cancer Observatory, 1.322 million new cancer cases were registered in India in 2020, while 2.72 million people had cancer for 5 years. A surge in cancer patients will drive the demand for monoclonal antibodies for cancer treatment.

Get Full Access: https://www.futuremarketinsights.com/reports/antibodies-market 

Key Segments Covered in Antibodies Market Study

By Disease Indication

• Cardiovascular diseases
• CNS disorders
• Cancer
• Autoimmune Disorders

By Product Type

• Monoclonal antibodies
• Polyclonal antibodies
• Antibody-drug complexes (ADCs) 

By End User

• Hospitals
• Long-term Care Facilities
• Research institutes

By Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• Japan
• Middle East and Africa (MEA)
  

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

Request a Complete TOC of this Report@ https://www.futuremarketinsights.com/toc/rep-gb-1330 

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Actinomycosis Market Size: The future of the actinomycosis market is looking bright, with growth projections reaching new heights in the coming years. According to Future Market Insights, the market is expected to achieve a staggering value of US$ 50 billion by the end of 2023.

Low-Grade Glioma Therapeutics Market Share: The global low-grade Glioma therapeutics market is expected to garner a market value of US$ 1038 Million in 2023 and is expected to accumulate a market value of US$ 1515.47 Million by registering a CAGR of 4.57% in the forecast period 2023-2033. 

Immunology-oncology ELISA Kits Market Growth: The future of the Immunology-oncology ELISA Kits market is looking incredibly bright as demand for these essential tools continues to soar. According to Future Market Insights, the market is expected to be worth US$ 20 billion by 2023, and this figure is only set to grow at a CAGR of 4.1% over the next decade, reaching US$ 30 billion by 2033.

Hypercoagulability Treatment Market Demand: The global hypercoagulability treatment market is expected to garner a market value of US$ 670 million in 2023 and is expected to accumulate a market value of US$ 1,317.99 million by registering a CAGR of 7% in the forecast period 2023 to 2033.

Medical Rehabilitation Robotics Market Opportunity: The global medical rehabilitation robotics market is forecasted to expand at 15.2% CAGR to reach a market valuation of US$ 1.76 Billion by the end of 2033, up from US$ 366.2 Million that was recorded for 2022.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

LinkedIn| Twitter| Blogs | YouTube

For Sales Enquiries: [email protected]

Old Source: https://www.globenewswire.com/fr/news-release/2022/08/18/2500538/0/en/Antibodies-Market-is-Forecast-to-Reach-a-Valuation-of-US-601-614-Billion-by-the-end-of-2031-Future-Market-Insights-Inc.html